Tus kws kho mob
QP95-19 New Drug, Reyvow™ (lasmiditan) Will Require Prior Authorization (PA)
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 27, 2019
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1471 - 1480 ntawm 4179
Tus kws kho mob
QP93-19 Provider Cost Data Update
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP99-19 Pharmacy Benefit Exclusion for Rapatha ®
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP96-19 Pharmacy Benefit Exclusion for PolivyTM, KanjintiTM, Evenity ®, BelrapzoTM, MvasiTM, Clinolipid 20%, Cisplatin, Heparin Sodium, and Selenious acid
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP94-19 MDH Syphilis Pregnancy Screening Guidelines
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP101-19 InterQual ® Level of Care Criteria for Concurrent Review Authorizations
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP100-19 Blue Distinction Center and Blue Distinction Center + Designations Being Applied to Ambulatory Surgical Centers for Spine, Knee and Hip Services
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP97-19 Commercial Product Changes for 2020
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 27, 2019
Tus kws kho mob
QP98-19 Changes to Blue Cross Mailing Addresses
Hnub Tim pib siv tau lub khoos kas: Lub Kaum Ib Hlis Ntuj Tim 27, 2019
Tus kws kho mob
Authorization and Release Form (PDF)